^
HR positive
HER2 Negative Breast Cancer
dalpiciclib
Sensitive
:
B
ESMO 2022 - 4 weeks - (New B)
ER positive
HER2 Negative Breast Cancer
RAD1901
Sensitive
:
B
ESMO 2022 - 4 weeks - (New B)
BRCA2 mutation + HR positive
HER2 Negative Breast Cancer
niraparib
Sensitive
:
C3
ESMO 2022 - 4 weeks - (New C3)
BRCA1 mutation + HR positive
HER2 Negative Breast Cancer
niraparib
Sensitive
:
C3
ESMO 2022 - 4 weeks - (New C3)
HR positive
HER2 Negative Breast Cancer
palbociclib
Sensitive
:
A1
HR positive
HER2 Negative Breast Cancer
ribociclib
Sensitive
:
A1
PIK3CA mutation + HR positive
HER2 Negative Breast Cancer
alpelisib
Sensitive
:
A1
HR positive
HER2 Negative Breast Cancer
abemaciclib
Sensitive
:
A1
HR positive
HER2 Negative Breast Cancer
everolimus
Sensitive
:
A1
BRCA2 mutation
HER2 Negative Breast Cancer
talazoparib
Sensitive
:
A1
BRCA1 mutation
HER2 Negative Breast Cancer
talazoparib
Sensitive
:
A1
BRCA1 mutation
HER2 Negative Breast Cancer
olaparib
Sensitive
:
A1
BRCA2 mutation
HER2 Negative Breast Cancer
olaparib
Sensitive
:
A1
HR positive
HER2 Negative Breast Cancer
fulvestrant
Sensitive
:
A1
HER-2 negative
HER2 Negative Breast Cancer
CaT
Sensitive
:
A2
HR positive
HER2 Negative Breast Cancer
sacituzumab govitecan-hziy
Sensitive
:
A2
HR negative + BRCA1 mutation
HER2 Negative Breast Cancer
olaparib
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
eribulin mesylate
Sensitive
:
A2
ER positive
HER2 Negative Breast Cancer
letrozole
Sensitive
:
A2
BRCA2 mutation
HER2 Negative Breast Cancer
PARP inhibitor
Sensitive
:
A2
BRCA1 mutation
HER2 Negative Breast Cancer
PARP inhibitor
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
ribociclib
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
docetaxel
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
paclitaxel
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
bevacizumab
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
albumin-bound paclitaxel
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
ixabepilone
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
capecitabine
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
gemcitabine
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
vinorelbine tartrate
Sensitive
:
A2
HR positive
HER2 Negative Breast Cancer
toremifene
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
letrozole
Sensitive
:
A2
ER positive
HER2 Negative Breast Cancer
anastrozole
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
docetaxel + capecitabine
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
tamoxifen
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
carboplatin + albumin-bound paclitaxel
Sensitive
:
A2